Biopharma’s Prospects Under A Second Trump Term: They Can’t Get Much Worse

 
• By Cathy Kelly
  
Trump flag
How would Trump's return to the White House impact pharma? • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet Perspectives

More from Pink Sheet